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Abstract  
AIM: A cross-sectional study was conducted at Saad Abualila Hospital (Khartoum, Sudan) to evaluate the vitamin 
D levels and thyroid function among pregnant Sudanese women (132) in early pregnancy. 
METHODS: A cross-sectional study was conducted at Saad Abualila hospital (Khartoum, Sudan) during the 
period from March to July 2015. Women who were in early pregnancy with a singleton pregnancy were 
approached to participate in the study after signing informed consent. A sample size of 132 participants was 
calculated guided by the normal interval of thyroid function in Sudanese women in the first trimester and not the 
level of 25(OH) vitamin D. The 25 - hydroxyvitamin D (25 (OH) vitamins levels were measured using an 
electrochemiluminescence immunoassay on an Elecsys 2010 Analyzer (Roche Diagnostics, Mannheim, 
Germany). 
RESULTS: The mean (SD) of age, gravidity and gestational age was 27.6 (5.5) years, 2.2 (1.6) and 10.4 (2.2) 
weeks, respectively. The mean (SD) of the body mass index (BMI) and haemoglobin was 27.1 (5.2) kg/m
2
 and 
10.8 (1.1) g/dl, respectively. Median (interquartile) values of TSH, FT3, and FT4 were 1.164 IU/ml (0.079 -
2.177 IU/ml), 4.639 nmol/l (3.843 - 6.562 nmol/l), and 16.86 pmol/l (13.02 - 31.48 pmol/l), respectively. There was 
no significant correlation between vitamin D levels and TSH, FT3 and FT4 
CONCLUSION: There is no correlation between 25 (OH) vitamin D levels and thyroid function during early 
pregnancy among Sudanese pregnant women, despite prevalent vitamin D deficiency among these women. 
 
 
 
 
 
 
Introduction 
 
Vitamin D is a fat-soluble vitamin and a 
steroid hormone precursor, which is primarily 
synthesized in the skin after exposure to ultraviolet B 
radiation. The liver is the first organ where 
hydroxylation occurs to produce 25 - hydroxyvitamin D 
(25(OH) D). Further hydroxylation continues mainly in 
the kidneys to produce the active form 1, 25 - 
dihydroxy vitamin D (1, 25(OH) 2D), besides the 
placenta and several other target organs [1]. In fact, 
less than 10% of vitamin D is derived from main 
dietary sources such as dairy, eggs, fish and meat [2] 
[3] [4]. Moreover, vitamin D has relatively durable 
stability over several weeks, and approximately 99% 
of circulating 25(OH) D3 is bound to vitamin D - 
binding proteins. Interestingly, its gradual oscillation 
depends on solar radiation rather than on vitamin D 
precursors that are gained from food items [5].   
 Vitamin D has many vital functions such as 
endocrine, autocrine (the activity of vitamin D3 arises 
from 1,25D synthesized within those cells), paracrine 
(1,25D is synthesized in one cell type and acts within 
adjacent cells), regulation of gene expression (it 
shares many pathways with p53), cell differentiation 
and proliferation [6] [7] [8]. Vitamin D receptors are 
found in many cells and tissues of the human body 
that are responsible for regulating the expression of 
more than 1000 genes in humans [9]. Allelic variants 
of the vitamin D - binding protein (DBP) gene enhance 
susceptibility to Graves' disease but not to 
Hashimoto's thyroiditis, which expresses the 
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endocrine role of vitamin D [10]. In contrast to this, 
some studies proposed an association between 
vitamin D deficiency and Hashimoto’s thyroiditis 
where a higher prevalence of vitamin D deficiency 
was reported among these patients [11] [12] [13]. At 
the same time, a significantly higher prevalence of 
vitamin D deficiency has been reported among 
patients with autoimmune thyroid disorders, 
hypothyroidism, overt hypothyroidism and Graves’ 
disease [14]. However, another study showed no 
significant relationship between non - autoimmune 
thyrotoxicosis and vitamin D status during pregnancy 
[15].  
Mazokopakis et al. observed an inverse 
correlation between low serum 25(OH) D levels in 
euthyroid patients with Hashimoto’s thyroiditis who 
had high serum anti-thyroid peroxidase (TPO) 
antibodies [16]. Despite the fact that many studies 
have evaluated the role of vitamin D in thyroid 
diseases, few studies explored the effects of 25 
(OH)D in association with thyroid function in 
pregnancy and maternal and foetal outcomes [17] 
[18]. Some data focused on the adverse events of the 
coincidental findings of both vitamin D deficiency and 
thyroid disorders during pregnancy: increased risk of 
preeclampsia, gestational hypertension, gestational 
diabetes mellitus, premature delivery and low birth 
weight [19] [20] [21] [22]. In vitro and in vivo studies 
propose an increased response to 1, 25(OH) 2D in the 
presence of T3 in cultured anterior pituitary cells.  
Moreover, an increased level of TSH is 
observed after acute administration of 1, 25(OH) 2D 
[23]. One study focused on this relationship and 
documented that high vitamin D status was 
associated with low circulating TSH in a younger 
group of patients [24]. On the other hand, Glinoer 
noted the enhancement of thyroid hormones and 
induced partial suppression of serum TSH in response 
to the sharp increase of human chorionic 
gonadotropin in the 1st trimester [25]. Another study 
from Sudan reported a suppressive effect of 
pregnancy on thyroid parameters TSH, FT4 and 
T3(26). 
Due to a higher global prevalence of vitamin 
D deﬁciency, increasing concern has been raised on 
maternal vitamin D deﬁciency and possible maternal 
and perinatal adverse effects [18] [27] [28]. There is a 
high prevalence of vitamin D deficiency (vitamin D 
level ≤ 20 ng/ml) among pregnant women in some 
tropical areas, e.g., 29% and 18.9 of women in Nigeria 
and southern China, respectively [29] [30]. There is no 
published data on vitamin D and thyroid function in 
Sudan. Hence, the current study was conducted to 
assess the association of thyroid function and vitamin 
D levels among Sudanese women in early pregnancy. 
 
 
Method 
 
A cross-sectional study was conducted at 
Saad Abualila hospital (Khartoum, Sudan) during the 
period from March to July 2015. Women who were in 
early pregnancy with a singleton pregnancy were 
approached to participate in the study after signing 
informed consent. A sample size of 132 participants 
was calculated guided by the normal interval of thyroid 
function in Sudanese women in the first trimester and 
not the level of 25(OH) vitamin D (no previous data). 
This sample size has over 80% power to detect a 
difference of 5% at α = 0.05. We assumed that 10% of 
the women might not respond or might have 
incomplete data. Exclusion criteria included chronic 
diseases of the liver and kidney, previous 
gastrointestinal surgery, pulmonary tuberculosis, 
lymphoma, primary hyperparathyroidism, 
hyperthyroidism, epilepsy on anticonvulsants therapy, 
intake of vitamin D within the last six months or on 
medications that could interfere with its metabolism 
such as glucocorticoids, and current anticonvulsant 
therapy.  
Sociodemographic and obstetric history were 
gathered using a questionnaire. The height and 
weight were measured using conventional methods 
and were used to calculate the body mass index (BMI) 
by using the formula: weight in kilograms (kg) divided 
by the square of the height in metres (m
2
). A blood 
sample was collected in a gold - top serum separator 
tube and allowed to clot. The samples were 
centrifuged at 1100 - 2000 g for 10 minutes. Serum 
then was separated from cells immediately and 
refrigerated at temperature 2 to 8°C before processing 
it. Grossly haemolysed, lipemic or samples containing 
particulate material were rejected. The 25 - 
hydroxyvitamin D (25 (OH) vitamins levels were 
measured using an electrochemiluminescence 
immunoassay on an Elecsys 2010 Analyzer (Roche 
Diagnostics, Mannheim, Germany). The normal level 
of 25 (OH) D is 20 ng/ml or above [31]. Thyroid 
function tests (TSH, T3and T4) were obtained using 
commercially available kits by Roche Elecsys Modular 
Analytics Cobas e411 utilising 
electrochemiluminescence immunoassay (Roche 
Diagnostics, Mannheim, Germany). Complete blood 
count was checked to assess haemoglobin (Hb) 
levels.  
 
Ethics 
The study received ethical approval from the 
board of the Department of Obstetrics and 
Gynaecology, Faculty of Medicine, University of 
Khartoum, Sudan. 
 
 
 Musa et al. Thyroid Function and 25 (OH) Vitamin D Level among Sudanese Women in Early Pregnancy  
_______________________________________________________________________________________________________________________________ 
_______________________________________________________________________________________________________________________________ 
Open Access Maced J Med Sci.                                                                                                                                                                                                         3 
 
Statistics 
Data were entered into a computer and SPSS 
for Windows was used for data analyses. Continuous 
data were checked for normality using the Shapiro -
Wilk test. Data were expressed as proportions: mean 
(SD) and median (interquartile). Correlation (Pearson 
and Spearman) were performed. P < 0.05 was 
considered statistically significant.  
 
 
Results 
 
One hundred – thirty - two women were 
enrolled in the study. The mean (SD) of age, gravidity 
and gestational age was 27.6 (5.5) years, 2.2 (1.6) 
and 10.4 (2.2) weeks, respectively. The majority 
(81.8%) of these women had urban residence and 
were housewives (75.8). The mean (SD) of the BMI 
and haemoglobin were 27.1 (5.2) kg/m
2
 and 10.8 (1.1) 
g/dl, respectively. The mean (SD) or median 
(interquartile) of TSH, FT3, FT4 and vitamin level are 
shown in Table 1.  
Table 1:  The level of thyroid hormones and 25 (OH) vitamin D 
level in Sudanese women in early pregnancy 
Variables   
                                        5-95%, mean (SD) of  
FT3, pmol/l 1.483─2.670, 2.022 (0.339) 
FT4, pmol/l  0.760─1.390, 1.072(1.972) 
                                    5-95%, median (interquartile) of  
TSH, m iU/l 0.579─3.424, 1.684 (1.163─2.104) 
25 (OH) vitamin D, ng/ml  5.3─16.1, 8.4(7.2─ 11.1) 
 
Except for one woman, all the participants 
(99.2%) demonstrated vitamin D deficiency. There is 
no correlation between 25 (OH) vitamin D, thyroid 
functions and BMI, Table 2. 
Table 2: Correlations between thyroid functions, BMI and 25 
(OH) vitamin D 
Variable  FT3 
r             P 
FT4 
r             P 
TSH 
r             P 
BMI 
r             P 
FT3  0.001    0.992 0.128   0.144 0.043   0.620 
FT4   - 0.122  0.202 -0.059  0.502 
TSH    0.033  0.711 
25 (OH) vitamin D 0.010  0.910 0.133   0.129 - 0.003  0.970 - 0.156  0.075 
 
  
 
Discussion 
 
The current study showed no significant 
association between vitamin D levels and thyroid 
functions among pregnant Sudanese women during 
the 1st trimester. This is in concordance with a 
previous study that was conducted among pregnant 
women in Northern China [32]. In the latter study, a 
high prevalence (96%) of vitamin D deficiency during 
the 1st trimester was reported [32]. Likewise, a non -
significant difference between vitamin D deficiency 
and thyroid antibodies status was reported in a case-
control study that recruited 531 pregnant women and 
238 age-matched, non - pregnant women as a control 
group [33]. Another study showed no correlation 
between 25 – Hydroxyvitamin D, FT4 and FT3 
hormone during pregnancy, but a significant 
correlation was observed among pregnant women 
with higher and sufficient levels of vitamin D (> 30.0 
ng/ml) and lower TSH [34]. These may be explained 
by the specific course of pregnancy that reflects the 
state of immune tolerance as the antithyroid 
autoantibody titers reduce by at least 50% from the 
1st to the 3rd trimester [35].  
Thus, a weak association between 25(OH) D 
and thyroid antibodies may result, leading to a non - 
significant relationship [32]. Hence, researchers 
speculated that both 25(OH) D and thyroid 
dysfunction might work independently and contribute 
to some of the same adverse effects during 
pregnancy [32]. We also propose that a higher level of 
human chorionic gonadotropin in the 1st trimester that 
influences TSH may be considered another 
contributing factor to weaken such coincidental 
effects. Moreover, no association was reported 
between vitamin D deficiency in non - pregnant 
women in both cases and control group, the 
hypothyroid and euthyroid subjects [36]. On the other 
hand, a significant correlation between vitamin D 
deficiency and all thyroid parameters (TSH, T4 and 
T3) have been documented among pregnant women 
in Italy [37].  
Furthermore, a significant correlation between 
vitamin D and TSH has been observed among 
pregnant women with a sufficient level of vitamin D (> 
30 ng/ml) [34]. A recent population-based health 
survey reported a higher prevalence of vitamin D 
deficiency and insufficiency in thyroglobulin antibodies 
(TgAb) positive cases which were 78.3% and 20% 
respectively [38]. Vitamin D deficiency has been 
reported as a risk factor for autoimmune thyroiditis 
and thyroid hypofunction [6] [39]. This may be 
explained by the unique immunomodulatory effect of 
1, 25 - (OH) 2D3 which is observed on T - lymphocyte 
function, antigen presenting cells and stimulated 
phagocytosis. It, therefore, inhibits the cytodestructive 
ability of T helper type - 1(Th1) lymphocytes, and 
enhances T helper type - 2(Th2) cytokine (Interleukin - 
4) production [40]. Both vitamin D and thyroid 
hormone share the same steroid hormone receptors 
[5].  
Nevertheless, there is some evidence that 
links vitamin D receptor gene polymorphisms with 
autoimmune thyroid diseases (AITD) [6]. The mutation 
of genes encoding for tissue hydroxylases and 
Vitamin D receptor additionally carries a potential risk 
of developing thyroid cancer [41]. In a case-control 
study, 53 patients with gestational transient 
thyrotoxicosis and 35 healthy pregnant women were 
recruited, and vitamin D levels were significantly lower 
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in cases when compared to the controls (11.1 ± 7.7 
and 16.5 ± 0.5 ng/mL, respectively) [42]. A previous 
study documented an association between 
pronounced decreased levels of 25(OH) D3 and 
Graves’ disease, in addition to an inverse correlation 
between 25(OH) D3 levels and thyroid gland volume 
[43]. Being a female may harbour a genetic risk for 
thyroid dysfunction, and global vitamin deficiency may 
influence the outcome of some studies. This is 
supported by a recent study that enrolled a total 
number of 1714 subjects (females = 1197 and males 
= 517) and showed significantly higher serum TSH 
levels, higher thyroid antibodies titers and lower 
serum 25(OH) vitamin D levels in females compared 
to males [38].  
The active calcitriol is promoted as a 
translocation regulator for T3 in the cerebellum by 
improving the binding capacity of the cytosolic T3 -
binding protein [44]. Moreover, it enhances TSH 
secretion of thyrotropin at the pituitary level [45]. The 
placental oestrogen stimulates Thyroxine Binding 
Globulin (TBG) synthesis [6]. The role of thyroid 
hormones is to stimulate intrauterine foetal growth, 
which is evident during the second half of gestation 
and has an influence on foetal metabolism [37]. 
Vitamin D deficiency has negative effects on thyroid 
functions, and when both coincide together during 
pregnancy, imminent harm may come to both mother 
and her foetus; hence, correction of both disorders is 
recommended to minimise risk. The limitations of this 
study are the seasonal variation for vitamin D levels 
and some laboratory tests that are not included, e.g., 
calcium, phosphorous, parathyroid hormones and 
thyroid antibodies. 
In conclusion, our study showed no significant 
association between vitamin D deficiency and thyroid 
function during the 1
st
 trimester among Sudanese 
pregnant women despite the higher prevalence of 
vitamin D deficiency. We recommend further studies 
in this area.  
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